Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India
JCO Global Oncology · 2025
DOI: 10.1200/go-25-00137 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2025. Verfasst von Chitrakshi Nagpal und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dr B.R.A. IRCH, AIIMS, New Delhi, India. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Germ-Line Mutation, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Genetic predisposition plays an important role in the pathogenesis of renal cell carcinoma. The prevalence of pathogenic/likely pathogenic (P/LP) in patients with renal cell cancer (RCC) is highly variable, and close to 40% of these can be missed with the current testing guidelines. METHODS This is a prospective study of all patients with metastatic RCC unselected for high-risk features, registered at our center between September 2023 and August 2024. Baseline clinicopathologic details were collected, and germline whole-exome sequencing was done on blood samples. Our aim was to determine the frequency of germline mutations in an unselected cohort of patients with metastatic RCC. Germline P/LP variants were visualized using cBioPortal, and chi-square and Mann-Whitney U tests were used to identify differences in patients with/without these variants. RESULTS Out of 140 participants, P/LP variants in cancer-predisposition genes were detected in 20%, and 4.2% were in RCC-associated genes. Fumarate hydratase was the most common RCC-associated variant (2.8%), while WT1 , BRCA1 , BRIP1, and ATM (1.4% each) were the commonest non–RCC-associated variants. RCC-associated genes were more frequent in non–clear cell histology ( P = .02); there was no difference in cancer predisposition genes on the basis of age, histology, or sex. CONCLUSION Patients with advanced RCC have a high prevalence of germline variants in both RCC-associated and non-RCC cancer-specific genes irrespective of the high-risk genetic features, signifying the importance of a baseline genetic evaluation in all patients with advanced RCC as it has implications for family screening and, in future, selection of therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Oncology, Dr B.R.A. IRCH, AIIMS, New Delhi, India.
- Department of Medical Oncology, National Cancer Institute, AIIMS, Jhajjar, India.
- Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology, New Delhi, India.
- Kusuma School of Biological Sciences, Indian Institute of Technology, New Delhi, India.
- Department of Lab Oncology, Dr B.R.A. IRCH, AIIMS, New Delhi, India.
- Department of Urology, AIIMS, New Delhi, India.
ORCID-Profile: Chitrakshi Nagpal, Mohit Kumar Divakar, Hemavathi Baskarane, Ghazal Tansir, Rishabh Jain, Aparna Sharma, Ranjit Kumar Sahoo, Sameer Bakhshi, Shilpi Minocha, Saran Kumar, Pranay Tanwar, Brusabhanu Nayak, Sridhar P, Atul Batra
Zitieren
APA
Nagpal, C., Divakar, M. K., Baskarane, H., Tansir, G., Jain, R., Sharma, A., Sahoo, R. K., Bakhshi, S., Gupta, I., Minocha, S., Kumar, S., Tanwar, P., Nayak, B., Nayyar, R., P, S., Kaushal, S., Ojha, S., Nangla, P., Haresh, K. P., …, & Batra, A. (2025). Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India. JCO Global Oncology. https://doi.org/10.1200/go-25-00137
Vancouver
Nagpal C, Divakar MK, Baskarane H, Tansir G, Jain R, Sharma A, et al. Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India. JCO Global Oncology. 2025. doi:10.1200/go-25-00137
BibTeX
@article{Nagpal2025,
author = {Nagpal, Chitrakshi and Divakar, Mohit Kumar and Baskarane, Hemavathi and Tansir, Ghazal and Jain, Rishabh and Sharma, Aparna and Sahoo, Ranjit Kumar and Bakhshi, Sameer and Gupta, Ishaan and Minocha, Shilpi and Kumar, Saran and Tanwar, Pranay and Nayak, Brusabhanu and Nayyar, Rishi and P, Sridhar and Kaushal, Seema and Ojha, Sanjay and Nangla, Parnika and Haresh, Kunhi Parambath and Seth, Amlesh and Batra, Atul},
title = {Prevalence of Germline Variants in Advanced Renal Cell Carcinoma in North India},
journal = {JCO Global Oncology},
year = {2025},
doi = {10.1200/go-25-00137}
}
EUVIMED